Data gathered: July 5
Alternative Data for Krystal Biotech
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 15 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 8,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | 22 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,701 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,120 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 43 | Sign up | Sign up | Sign up |
| Linkedin Employees | 283 | Sign up | Sign up | Sign up |
About Krystal Biotech
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States.
| Price | $143.08 |
| Target Price | Sign up |
| Volume | 167,250 |
| Market Cap | $4.13B |
| Year Range | $123.36 - $199.61 |
| Dividend Yield | 0% |
| PE Ratio | 34.39 |
| Analyst Rating | 88% buy |
| Industry | Biotechnology |
In the news
 |
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 YearsJuly 4 - Biztoc.com |
 |
Krystal Biotech Q2 EPS Estimate Reduced by HC WainwrightJuly 2 - ETF Daily News |
 |
Krystal Biotech, Inc.'s (NASDAQ:KRYS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?July 1 - Yahoo |
|
FY2026 EPS Forecast for Krystal Biotech Decreased by AnalystJuly 1 - ETF Daily News |
 |
Insider Decision Unfolding At Krystal Biotech: Christopher Mason Exercises Options, Resulting In $0July 1 - Biztoc.com |
 |
Breaking Update: Everett Rand Sutherland Engages In Options Exercise At Krystal Biotech Realizing $0July 1 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 88M | 5M | 83M | 36M | 38M | 1.196 |
| Q4 '24 | 91M | 4.9M | 86M | 45M | 43M | 1.530 |
| Q3 '24 | 84M | 6.7M | 77M | 27M | 31M | 0.910 |
| Q2 '24 | 70M | 8M | 62M | 16M | 18M | 0.530 |
| Q1 '24 | 45M | 2.4M | 43M | 930,000 | 2.5M | 0.030 |
Insider Transactions View All
| Krishnan Krish S filed to sell 1,556,956 shares at $175.8. March 13 '25 |
| Krishnan Krish S filed to sell 1,533,056 shares at $179.6. March 13 '25 |
| Krishnan Krish S filed to sell 1,463,711 shares at $179.5. March 13 '25 |
| Krishnan Krish S filed to sell 1,487,072 shares at $176. March 13 '25 |
| Krishnan Krish S filed to sell 1,482,493 shares at $176.9. March 13 '25 |
Similar companies
Read more about Krystal Biotech (KRYS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Krystal Biotech?
The Market Cap of Krystal Biotech is $4.13B.
What is Krystal Biotech's PE Ratio?
As of today, Krystal Biotech's PE (Price to Earnings) ratio is 34.39.
What is the current stock price of Krystal Biotech?
Currently, the price of one share of Krystal Biotech stock is $143.08.
How can I analyze the KRYS stock price chart for investment decisions?
The KRYS stock price chart above provides a comprehensive visual representation of Krystal Biotech's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Krystal Biotech shares. Our platform offers an up-to-date KRYS stock price chart, along with technical data analysis and alternative data insights.
Does KRYS offer dividends to its shareholders?
As of our latest update, Krystal Biotech (KRYS) does not offer dividends to its shareholders. Investors interested in Krystal Biotech should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Krystal Biotech?
Some of the similar stocks of Krystal Biotech are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.